论文部分内容阅读
目的:对银杏达莫联合奥扎格雷静脉滴注在脑梗死患者中的治疗效果进行分析。方法:选择黔南州人民医院2010年1月至2015年12月收治的78例脑梗死患者,将所有患者随机分为观察组和对照组,各39例,观察组患者采用银杏达莫联合奥扎格雷治疗,对照组患者采用奥扎格雷治疗,观察两组患者疗效。结果:观察组患者有效率为89.7%,对照组为79.5%,组间比较,差异具有统计学意义(P<0.05)。两组患者治疗前脑卒中评分比较,差异无统计学意义(P>0.05),治疗后观察组患者脑卒中评分为(16.8±5.9)分,明显低于治疗前以及对照组患者治疗后的脑卒中评分,差异无统计学意义(P>0.05)。结论:银杏达莫联合奥扎格雷静脉滴注在脑梗死患者中的治疗效果更为显著。
OBJECTIVE: To analyze the therapeutic effect of ginkgo dipyridamole combined with ozagrel intravenous drip in patients with cerebral infarction. Methods: 78 patients with cerebral infarction who were admitted to Qiannan Prefecture People’s Hospital from January 2010 to December 2015 were enrolled. All patients were randomly divided into observation group and control group, with 39 cases in each group. The patients in observation group were treated with Ginkgo biloba Zagre treatment, the control group of patients treated with ozagrel, the efficacy of two groups were observed. Results: The effective rate of the observation group was 89.7% and that of the control group was 79.5%. There was significant difference between the two groups (P <0.05). There was no significant difference in stroke scores between the two groups before treatment (P> 0.05). After treatment, the score of stroke in the observation group was (16.8 ± 5.9) points, which was significantly lower than that before treatment and in the control group Stroke score, the difference was not statistically significant (P> 0.05). Conclusion: The effect of Yinxingdamo combined with Ozagrel intravenous drip in patients with cerebral infarction is more significant.